Implantable Cardiac Monitors: Evolution Through Disruption.

ABSTRACT: Syncope and stroke are commonly seen in clinical practice, and the diagnostic workup is often time-consuming and costly and may increase resource utilization in the health-care system. The use of implantable cardiac monitors (ICMs) in syncope evaluation has been well studied, but their use in cryptogenic stroke evaluation and anticoagulation management in patients with atrial fibrillation (AF) is still emerging. The standard workup of the syncope patient or those at risk for a possible cardioembolic stroke includes the utilization of external cardiac monitors; however, these devices cannot provide long-term arrhythmia assessment, whereas ICMs can now last up to three years, increasing the possibility of arriving at a diagnosis. Recent studies have shown that ICM use may shorten the time to

SUBMITTER: Sandesara CM 

PROVIDER: S-EPMC7252697 | biostudies-literature | 2017 Sep

REPOSITORIES: biostudies-literature